200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 19875-60-6
19875-60-6 | Urea, N'-[(8α)-9,10-didehydro-6-methylergolin-8-yl]-N,N-diethyl-, (2Z)-2-butenedioate (1:1)
CAS No: 19875-60-6 Catalog No: AG002BQ8 MDL No:
Product Description
Catalog Number:
AG002BQ8
Chemical Name:
Urea, N'-[(8α)-9,10-didehydro-6-methylergolin-8-yl]-N,N-diethyl-, (2Z)-2-butenedioate (1:1)
CAS Number:
19875-60-6
Molecular Formula:
C24H30N4O5
Molecular Weight:
454.5188
IUPAC Name:
3-[(6aR,9S)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinolin-9-yl]-1,1-diethylurea;(Z)-but-2-enedioic acid
InChI:
InChI=1S/C20H26N4O.C4H4O4/c1-4-24(5-2)20(25)22-14-10-16-15-7-6-8-17-19(15)13(11-21-17)9-18(16)23(3)12-14;5-3(6)1-2-4(7)8/h6-8,10-11,14,18,21H,4-5,9,12H2,1-3H3,(H,22,25);1-2H,(H,5,6)(H,7,8)/b;2-1-/t14-,18+;/m0./s1
InChI Key:
CVQFAMQDTWVJSV-BAXNFHPCSA-N
SMILES:
OC(=O)/C=C\C(=O)O.CCN(C(=O)N[C@@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c[nH]3)CC
EC Number:
243-387-3
UNII:
UV1635N8XW
Properties
Complexity:
663
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2
Defined Atom Stereocenter Count:
2
Defined Bond Stereocenter Count:
1
Exact Mass:
454.222g/mol
Formal Charge:
0
Heavy Atom Count:
33
Hydrogen Bond Acceptor Count:
6
Hydrogen Bond Donor Count:
4
Isotope Atom Count:
0
Molecular Weight:
454.527g/mol
Monoisotopic Mass:
454.222g/mol
Rotatable Bond Count:
5
Topological Polar Surface Area:
126A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
| Title | Journal |
|---|---|
| Pathways in pulmonary arterial hypertension: the future is here. | European respiratory review : an official journal of the European Respiratory Society 20121201 |
| [Prescription of ergot derivatives for lactation inhibition in France: Current practices]. | Journal de gynecologie, obstetrique et biologie de la reproduction 20120401 |
| Antiserotonergic properties of terguride in blood vessels, platelets, and valvular interstitial cells. | The Journal of pharmacology and experimental therapeutics 20120201 |
| Terguride for pulmonary arterial hypertension. | Expert opinion on therapeutic targets 20111101 |
| Effects of lisuride hydrogen maleate on pericontusional tissue metabolism, brain edema formation, and contusion volume development after experimental traumatic brain injury in rats. | Neuroscience letters 20110725 |
| Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats. | The European respiratory journal 20110501 |
| The dopamine D(2) partial agonist and antagonist terguride decreases heroin self-administration on fixed- and progressive-ratio schedules. | Pharmacology, biochemistry, and behavior 20101201 |
| Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention. | Thorax 20101101 |
| Anticonvulsive effects of the dopamine agonist lisuride maleate after experimental traumatic brain injury. | Neuroscience letters 20100212 |
| LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor. | Psychopharmacology 20100201 |
| Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. | Arthritis and rheumatism 20100101 |
| Co-administration of the partial dopamine D2 agonist terguride with L-dopa attenuates L-dopa-induced locomotor sensitization in hemiparkinsonian mice. | Behavioural brain research 20090914 |
| Use of apomorphine in Parkinson's disease. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20081201 |
| The effect of terguride in carbon tetrachloride-induced liver fibrosis in rat. | Experimental biology and medicine (Maywood, N.J.) 20081101 |
| Both mild hypothermia and dopamine D(2) agonist are neuroprotective against hyperthermia-induced injury in PC12 cells. | Neuroscience letters 20081010 |
| Effect of dopaminergic substances on sleep/wakefulness in saline- and MPTP-treated mice. | Journal of sleep research 20080301 |
| Effects of aripiprazole and terguride on dopamine synthesis in the dorsal striatum and medial prefrontal cortex of preweanling rats. | Journal of neural transmission (Vienna, Austria : 1996) 20080101 |
| [A case of ruptured internal carotid artery aneurysm mimicking pituitary apoplexy]. | No shinkei geka. Neurological surgery 20071201 |
| Long-term serotonin effects in the rat are prevented by terguride. | Regulatory peptides 20071004 |
| In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling. | Journal of psychopharmacology (Oxford, England) 20070801 |
| Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. | Neuron 20070201 |
| In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist. | Synapse (New York, N.Y.) 20061215 |
| Striking differences of action of lisuride stereoisomers at histamine H1 receptors. | Naunyn-Schmiedeberg's archives of pharmacology 20061201 |
| Observed smoking in cars: a method and differences by socioeconomic area. | Tobacco control 20061001 |
| Glutamate-induced cell death and formation of radicals can be reduced by lisuride in mesencephalic primary cell culture. | Journal of neural transmission (Vienna, Austria : 1996) 20060901 |
| Dopamine stimulation via infusion in the lateral ventricle. | Annals of the New York Academy of Sciences 20060801 |
| Homology modelling of the serotoninergic 5-HT2c receptor. | Journal of enzyme inhibition and medicinal chemistry 20060601 |
| Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat. | European journal of pharmacology 20060327 |
| The partial dopamine D2-like receptor agonist terguride functions as an agonist in preweanling rats after a 5-day reserpine regimen. | Psychopharmacology 20060301 |
| Effects of terguride, ropinirole, and acetyl-L-carnitine on methamphetamine withdrawal in the rat. | Pharmacology, biochemistry, and behavior 20060301 |
| Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats. | Brain research 20060216 |
| Transdermal lisuride: short-term efficacy and tolerability study in patients with severe restless legs syndrome. | Sleep medicine 20060101 |
| Lisuride treatment of restless legs syndrome: first studies with monotherapy in de novo patients and in combination with levodopa in advanced disease. | Journal of neural transmission (Vienna, Austria : 1996) 20060101 |
| Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis. | Clinical neuropharmacology 20060101 |
| Dopamine and serotonin modulate the onset of metamorphosis in the ascidian Phallusia mammillata. | Developmental biology 20050601 |
| Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic. | European journal of pharmacology 20050516 |
| Levodopa in the treatment of Parkinson's disease: current controversies. | Movement disorders : official journal of the Movement Disorder Society 20050501 |
| Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. | Movement disorders : official journal of the Movement Disorder Society 20050501 |
| Influence of steric hindrance on enantioseparation of Dns-amino acids and pesticides on terguride based chiral selectors in capillary electrophoresis. | Journal of separation science 20050501 |
| The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone: evidence from preweanling rats. | Psychopharmacology 20050401 |
| Capillary zone electrophoresis separation of enantiomers of lisuride. | Journal of chromatography. A 20050225 |
| Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050101 |
| Regulation of serotonin 5-HT2C receptors by chronic ligand exposure. | European journal of pharmacology 20040913 |
| The effects of dopamine receptor agonists and antagonists on the secretory rate of cockroach (Periplaneta americana) salivary glands. | Journal of insect physiology 20040901 |
| 8R-lisuride is a potent stereospecific histamine H1-receptor partial agonist. | Molecular pharmacology 20040301 |
| No evidence of the usefulness of eye blinking as a marker for central dopaminergic activity. | Journal of psychopharmacology (Oxford, England) 20040301 |
| Pergolide, terguride and N,N'-spacer-linked oligomers of both interact with 5-HT2A receptors of rat tail artery. | Physiological research 20040101 |
| LSD, 5-HT (serotonin), and the evolution of a behavioral assay. | Neuroscience and biobehavioral reviews 20040101 |
| Transdermal lisuride delivery in the treatment of Parkinson's disease. | Journal of neural transmission. Supplementum 20040101 |
| Effects of terguride treatment on glucose abnormalities induced by ischemic brain damage in SHR/N-cp lean Koletsky strain and in rats of Wistar strain. | Bratislavske lekarske listy 20040101 |
| The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration. | Experimental neurology 20031101 |
| Management of restless legs syndrome by the partial D2-agonist terguride. | Sleep medicine 20030901 |
| Cortisol as an indicator of dopaminergic effects on nicotine craving. | Human psychopharmacology 20030801 |
| Effects of a partial dopamine D2-like agonist on the cocaine-induced behavioral sensitization of preweanling rats. | Pharmacology, biochemistry, and behavior 20030801 |
| [Pharmacokinetic/pharmacodynamic analysis of anti-hyperprolactinemic effect of terguride based on dopamine D2 receptor occupancy]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20030401 |
| Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys. | Psychopharmacology 20030301 |
| Inhibition of growth hormone excess reduces insulin resistance and ovarian dysfunction in a lean case of polycystic ovary syndrome with a growth-hormone-producing pituitary adenoma. | Hormone research 20030101 |
| [Arrest of lactation after 2nd trimester abortion with a single dose of cabergoline in comparison with 10-day administration of teguride]. | Ceska gynekologie 20030101 |
| [Results of treatment for male prolactinomas]. | No shinkei geka. Neurological surgery 20021201 |
| Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats. | Psychopharmacology 20021001 |
| Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease. | Brain : a journal of neurology 20020901 |
| The trigonometric responder approach: a new method for detecting responders to pharmacological or experimental challenges. | Pharmacopsychiatry 20020901 |
| Terguride treatment attenuated prolactin release and enhanced insulin receptor affinity and GLUT 4 content in obese spontaneously hypertensive female, but not male rats. | Annals of the New York Academy of Sciences 20020601 |
| Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine? | European journal of pharmacology 20020329 |
| Clustered ergot alkaloids modulate cell-mediated cytotoxicity. | Bioorganic & medicinal chemistry 20020201 |
| Lisuride, a dopamine D2 receptor agonist, and anticraving drug expectancy as modifiers of relapse in alcohol dependence. | Progress in neuro-psychopharmacology & biological psychiatry 20020201 |
| Protection of dopaminergic neurons in primary culture by lisuride. | Journal of neural transmission (Vienna, Austria : 1996) 20020201 |
| DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20020101 |
| DA agonists -- ergot derivatives: lisuride: management of Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20020101 |
| [Use of dopamine agonists in the treatment of Parkinson's disease]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20020101 |
| Quantitative analysis of striatal dopamine D2 receptors with 123 I-iodolisuride SPECT in degenerative extrapyramidal diseases. | Nuclear medicine communications 20011101 |
| Dopaminergic modulation of grooming behavior in virgin and pregnant rats. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20011101 |
| Dopamine partial agonist reverses amphetamine withdrawal in rats. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20011101 |
| Poetic talent unmasked by treatment of Parkinson's disease. | Movement disorders : official journal of the Movement Disorder Society 20011101 |
| Real-time analysis of dopamine: antagonist interactions at recombinant human D2long receptor upon modulation of its activation state. | British journal of pharmacology 20010901 |
| Symptomatic treatment of premenstrual mastalgia in premenopausal women with lisuride maleate: a double-blind placebo-controlled randomized study. | Fertility and sterility 20010401 |
| A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule. | Pharmacology, biochemistry, and behavior 20010401 |
| [Parkinson disease: diagnostic and therapeutic criteria]. | Presse medicale (Paris, France : 1983) 20010303 |
| Long-duration effect and the postsynaptic compartment: study using a dopamine agonist with a short half-life. | Movement disorders : official journal of the Movement Disorder Society 20010301 |
| Efficacy and tolerability of dopamine agonists in a parkinsonian population. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20010201 |
| The influence of personality on nicotine craving: a hierarchical multivariate statistical prediction model. | Neuropsychobiology 20010101 |
| Clinical features and medical treatment of male prolactinomas. | Acta neurochirurgica 20010101 |
| Nonlinear analysis of partial dopamine agonist effects on cAMP in C6 glioma cells. | Journal of pharmacological and toxicological methods 20010101 |
| Atypical polypoid adenomyoma in a patient with hyperprolactinemia. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20010101 |
| Terguride attenuates prolactin levels and ameliorates insulin sensitivity and insulin binding in obese spontaneously hypertensive rats. | Physiological research 20010101 |
| Sleep attacks and Parkinson's disease treatment. | Lancet (London, England) 20000415 |
| Pharmacological effects of BAM-1120, a novel ergoline derivative, on central dopaminergic functions in rats. | Methods and findings in experimental and clinical pharmacology 19980901 |
| Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. | Experimental neurology 19980601 |
| Postpartum cerebral angiopathy with intracerebral hemorrhage in a patient receiving lisuride. | Neurology 19980401 |
| Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy. | Naunyn-Schmiedeberg's archives of pharmacology 19970601 |
| Involvement of dopamine D2 receptors in the effect of cocaine on sexual behaviour and stretching-yawning of male rats. | Neuropharmacology 19970601 |
| Effects of terguride on anterior pituitary function in parkinsonian patients treated with L-dopa: a double-blind study versus placebo. | Clinical neuropharmacology 19960201 |
| Is alpha-methyldopa-type autoimmune hemolytic anemia mediated by interferon-gamma? | Annals of hematology 19941101 |
| [Therapeutic effect of lisuride maleate on post-stroke depression]. | Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 19940101 |
| Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol. | European journal of pharmacology 19930624 |
| Effects of terguride, a partial D2 agonist, on MPTP-lesioned parkinsonian cynomolgus monkeys. | Annals of neurology 19930501 |
| Extrapyramidal syndrome responsive to dopaminergic treatment following recovery from central pontine myelinolysis. | European neurology 19930101 |
| Transient left bundle branch block following intravenous lisuride bolus. | Fundamental & clinical pharmacology 19930101 |
| Partial dopamine agonist therapy of levodopa-induced dyskinesias. | Neurology 19920601 |
| Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification. | Movement disorders : official journal of the Movement Disorder Society 19920101 |
| Antagonist effect of terguride in Parkinson's disease. | Clinical neuropharmacology 19911001 |
| Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibition of d-amphetamine-induced locomotor hyperactivity and stereotypy. | Psychopharmacology 19910101 |
| Subcutaneous administration of lisuride in the treatment of complex motor fluctuations in Parkinson's disease. | Journal of neural transmission. Supplementum 19880101 |
| Continuous subcutaneous lisuride infusions in Parkinson's disease. | Journal of neural transmission. Supplementum 19880101 |
| Treatment of Parkinson's disease with subcutaneous lisuride infusions. | Journal of neural transmission. Supplementum 19880101 |
| Lisuride infusion pump in Parkinson's disease. A report of two cases. | Journal of neural transmission. Supplementum 19880101 |
| Transdihydrolisuride in parkinsonism. | Clinical neuropharmacology 19870101 |
| Studies on the involvement of dopamine D-1 and D-2 receptors in the anticonvulsant effect of dopamine agonists in various rodent models of epilepsy. | European journal of pharmacology 19860822 |
| The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson disease. | The American journal of the medical sciences 19850901 |
| Novel 8 alpha-ergolines with inhibitory and stimulatory effects on prolactin secretion in rats. | Life sciences 19841029 |
| Drug-induced modulation of locomotor hyperactivity induced by picrotoxin in nucleus accumbens. | Pharmacology, biochemistry, and behavior 19841001 |
| Use of ergot derivative lisuride in Parkinson's disease. | Advances in neurology 19840101 |
| [Acid lysuride maleate in the prevention of migraine headache. Clinical experience]. | Minerva medica 19830714 |
| Anwesenheit: psychopathology and clinical associations. | The British journal of psychiatry : the journal of mental science 19821201 |
| Influence of lisuride on morphine withdrawal signs in the rat: a dopamine-mimetic effect. | Psychopharmacology 19820101 |
| Action of lisuride on reserpine-induced muscular rigidity in rats after local application into the striatum, ventricular space or the spinal subarachnoid space. | Arzneimittel-Forschung 19820101 |
| Depression of reserpine-induced muscular rigidity in rats after administration of lisuride into the spinal subarachnoid space. | Naunyn-Schmiedeberg's archives of pharmacology 19800101 |
| Suppression of prolactin secretion by lisuride throughout the menstrual cycle and in hyperprolactinaemic menstrual disorders. | Acta endocrinologica 19790901 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.